Secondary acute lymphoblastic leukaemia in a multiple myeloma patient

Por Piszcz, Jaroslaw, Bolkun, Lukasz, Cichocka, Edyta, Kloczko, Janusz
Publicado em 2013

Maintaining plasma quality and safety in the state of ongoing epidemic – The role of pathogen reduction

Por Wasiluk, Tomasz, Rogowska, Anna, Boczkowska-Radziwon, Barbara, Zebrowska, Agnieszka, Bolkun, Lukasz, Piszcz, Jaroslaw, Radziwon, Piotr
Publicado no Transfus Apher Sci (2021)

To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients

Por Piszcz, Jaroslaw, Armitage, Emily G., Ferrarini, Alessia, Rupérez, Francisco J., Kulczynska, Agnieszka, Bolkun, Lukasz, Kloczko, Janusz, Kretowski, Adam, Urbanowicz, Alina, Ciborowski, Michal, Barbas, Coral
Publicado no Oncotarget (2016)

Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia

Por Helbig, Grzegorz, Moskwa, Andrzej, Hus, Marek, Piszcz, Jarosław, Swiderska, Alina, Urbanowicz, Alina, Całbecka, Małgorzata, Seferyńska, Ilona, Raźny, Małgorzata, Rodzaj, Marek, Żuk, Ewa, Kyrcz-Krzemień, Sławomira
Publicado em 2011